ES3028665T3 - Scd83 for wound healing, hair growth, and skin and hair care - Google Patents

Scd83 for wound healing, hair growth, and skin and hair care Download PDF

Info

Publication number
ES3028665T3
ES3028665T3 ES21717933T ES21717933T ES3028665T3 ES 3028665 T3 ES3028665 T3 ES 3028665T3 ES 21717933 T ES21717933 T ES 21717933T ES 21717933 T ES21717933 T ES 21717933T ES 3028665 T3 ES3028665 T3 ES 3028665T3
Authority
ES
Spain
Prior art keywords
scd83
protein
scd83 protein
dimeric
functional derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES21717933T
Other languages
English (en)
Spanish (es)
Inventor
Alexander Steinkasserer
Elisabeth Zinser
Dmytro Royzman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Friedrich Alexander Universitaet Erlangen Nuernberg
Original Assignee
Friedrich Alexander Universitaet Erlangen Nuernberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Friedrich Alexander Universitaet Erlangen Nuernberg filed Critical Friedrich Alexander Universitaet Erlangen Nuernberg
Application granted granted Critical
Publication of ES3028665T3 publication Critical patent/ES3028665T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES21717933T 2020-04-16 2021-04-16 Scd83 for wound healing, hair growth, and skin and hair care Active ES3028665T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20169899.0A EP3895723A1 (en) 2020-04-16 2020-04-16 Scd83 for wound healing, hair growth, and skin and hair care
PCT/EP2021/059923 WO2021209607A1 (en) 2020-04-16 2021-04-16 Scd83 for wound healing, hair growth, and skin and hair care

Publications (1)

Publication Number Publication Date
ES3028665T3 true ES3028665T3 (en) 2025-06-19

Family

ID=70294945

Family Applications (1)

Application Number Title Priority Date Filing Date
ES21717933T Active ES3028665T3 (en) 2020-04-16 2021-04-16 Scd83 for wound healing, hair growth, and skin and hair care

Country Status (11)

Country Link
US (1) US20230270820A1 (https=)
EP (3) EP3895723A1 (https=)
JP (1) JP2023522022A (https=)
CA (1) CA3175640A1 (https=)
ES (1) ES3028665T3 (https=)
HR (1) HRP20250640T1 (https=)
HU (1) HUE072389T2 (https=)
PL (1) PL4135745T3 (https=)
RS (1) RS66881B1 (https=)
SM (1) SMT202500330T1 (https=)
WO (1) WO2021209607A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102024110866A1 (de) 2024-04-18 2025-10-23 Christian Arnold Pharmazeutische Zusammensetzung zur Heilung einer Wunde

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1422241A1 (en) 2002-11-19 2004-05-26 Alexander Steinkasserer Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
CA2725198A1 (en) * 2008-05-23 2009-11-26 Argos Therapeutics, Inc. Novel soluble cd83 polypeptides, formulations and methods of use
JP2013040160A (ja) * 2011-07-01 2013-02-28 Genentech Inc 自己免疫疾患を治療するための抗ｃｄ８３アゴニスト抗体の使用

Also Published As

Publication number Publication date
EP4135745C0 (en) 2025-05-07
JP2023522022A (ja) 2023-05-26
EP4591944A3 (en) 2025-10-01
PL4135745T3 (pl) 2025-09-15
CA3175640A1 (en) 2021-10-21
EP4135745B1 (en) 2025-05-07
SMT202500330T1 (it) 2025-11-10
EP3895723A1 (en) 2021-10-20
HRP20250640T1 (hr) 2025-09-12
WO2021209607A1 (en) 2021-10-21
EP4135745A1 (en) 2023-02-22
US20230270820A1 (en) 2023-08-31
RS66881B1 (sr) 2025-07-31
HUE072389T2 (hu) 2025-11-28
EP4591944A2 (en) 2025-07-30

Similar Documents

Publication Publication Date Title
ES2289778T3 (es) Proteinas de fusion de la region constante de la inmunoglobulina/receptor tgf-beta tipo ii.
ES2426420T3 (es) Péptidos de queratina bioactivos
Herrera et al. Human liver stem cells improve liver injury in a model of fulminant liver failure
ES2400920T3 (es) Péptidos eficaces en el tratamiento de tumores y otras afecciones que requieren la eliminación o la destrucción de células
US20060057680A1 (en) Mutant interleukin-15 polypeptides
US8895003B2 (en) Pharmaceutical composition comprising EDA-1 Fusion Protein
ES2398039T3 (es) Uso de anticuerpos antagonistas anti-TGF-beta para tratar o prevenir la pérdida de función renal
CN113194978A (zh) 具有间充质干细胞的动员活性的肽
US9351914B2 (en) Methods for modulating hair growth using truncated laminin-511
JP2008546707A (ja) 創傷治癒
Loo et al. Discovery of hyperstable noncanonical plant-derived epidermal growth factor receptor agonist and analogs
ES3028665T3 (en) Scd83 for wound healing, hair growth, and skin and hair care
JP2017500316A (ja) ストロマ細胞由来因子−１のプロテアーゼ耐性変異体を用いた、組織損傷を修復する方法
KR20080031405A (ko) 상피 재생의 촉진
US20230241159A1 (en) Peptide Having Mesenchymal Stem Cell Mobilizing Activity
ES2218666T3 (es) Producto a base del factor de crecimiento de queratinocitos-2 (kggf-2).
AU2018247928A1 (en) C4BP-based compounds for treating immunological diseases
ES2297286T3 (es) Uso de productos proteicos del factor de crecimiento de queratinocitos-2.
HK40129498A (en) Scd83 for wound healing, hair growth, and skin and hair care
US20240197827A1 (en) Psg1 for use in the treatment of osteoarthritis
US20240189390A1 (en) Treatment of cerebrovascular events and neurological disorders
US11524091B2 (en) GILZ formulations for wound healing
US20090130070A1 (en) Method of treatment
Class et al. Patent application title: Methods for Modulating Hair Growth Using Truncated Laminin-511 Inventors: M. Peter Marinkovich (Redwood City, CA, US) Jing Gao (Mountain View, CA, US) Xiaoyu Xu (Foster City, CA, US) Jayakumar Rajadas (Cupertino, CA, US) Jayakumar Rajadas (Cupertino, CA, US)
US20210138043A1 (en) Compounds and methods for the immobilization of myostatin-inhibitors on the extracellular matrix by transglutaminase